"Adaptogen" is a regulatory category (Soviet Lazarev/Brekhman 1947-69) for non-specific stress-resistance modulators acting on HPA axis + monoamines + heat-shock proteins. Mechanism evidence is patchier than pharmaceutical pathways — most adaptogen claims rest on traditional use + animal pharmacology + small clinical trials with mixed outcomes. Ashwagandha (Withania somnifera) lowers cortisol in chronic-stress samples (Indian Ayurvedic). Rhodiola rosea contains salidroside + rosavins → MAO inhibition + 5-HT modulation. Panax ginseng (Korean/American) ginsenosides modulate HPA + nitric oxide. Eleuthero (Siberian "ginseng") — separate genus, similar use. Bacopa monnieri → bacosides + cerebral blood flow + AChE modulation. Holy basil (tulsi), schisandra, maca, gotu kola, astragalus all marketed in the same category. Mechanism prose herein reflects current consensus — many specific claims need full-text trial citation for kinetic parameters.
Organ Systems
endocrine
nervous
Pathway Steps
chronic-psychophysical-stress → hpa-axis-dysregulation — via sustained cortisol elevation + reduced negative feedback sensitivity. Chronic physical or psychological stress dysregulates the HPA axis — flattening cortisol rhythms and impairing feedback — a state linked to fatigue and metabolic/mood disturbance. This maladaptive stress response is the target adaptogens are proposed to normalize.
adaptogen-extract → normalized-hpa-output — via mechanism varies — monoamine modulation + HSP induction + cortisol-curve flattening. Adaptogens (Rhodiola, ashwagandha, Eleutherococcus) are proposed stress-response modulators that nudge a dysregulated HPA axis back toward balance (a hormesis/“eustress” concept) rather than simply stimulating or sedating. Clinical evidence is mixed and mechanisms remain incompletely defined.
Known Modulators
ashwagandha (inhibitor) — HPA cortisol output (down). Withania somnifera; meta-analyses show cortisol reduction + sleep/anxiety improvement in chronically-stressed samples
ashwagandha ksm66 (inhibitor) — HPA cortisol output (standardized extract). standardized to 5% withanolides; commonly studied form in clinical trials
maca (activator) — no specific receptor target identified. Lepidium meyenii Peruvian root; libido + energy claims; mechanism not specifically established
astragalus (activator) — immune modulation + telomerase activation (TA-65). Astragalus membranaceus; TCM tonic; astragaloside IV cited for cardiovascular + anti-aging
gotu kola (activator) — collagen synthesis + GABA-A potentiation. Centella asiatica; asiaticoside actives; wound healing + cognitive use
beetroot extract (activator) — NO release (dietary nitrate). NO precursor; endurance performance + BP signal
red yeast rice (inhibitor) — HMG-CoA reductase (monacolin K = lovastatin). natural statin; monacolin K is chemically lovastatin; not standardized → variable potency
withaferin a (inhibitor) — HPA cortisol (indirect, via anti-inflammatory + glucocorticoid axis modulation). Dominant bioactive in Sensoril ashwagandha (leaf-enriched); contributes to the anti-stress profile of leaf-containing extracts.
withanolide a (inhibitor) — HPA cortisol (via GABA-A + NF-κB pathways). Root-enriched bioactive in KSM-66 standardized extracts; primary mediator of the cortisol-lowering effect of ashwagandha root.
sitoindoside ix (inhibitor) — HPA cortisol (preclinical anti-stress). Marker glycowithanolide; preclinical immunomodulatory + anti-stress activity. Most-studied of the sitoindoside class.